{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:34:42Z","timestamp":1792305282719,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.autrev.2022.103261","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T20:02:33Z","timestamp":1671480153000},"page":"103261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Systemic sclerosis associated myopathy"],"prefix":"10.1016","volume":"22","author":[{"given":"Benjamin","family":"Chaigne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"L\u00e9onard-Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10103","key":"10.1016\/j.autrev.2022.103261_bb0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2022.103261_bb0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103261_bb0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1422.029","article-title":"Systemic sclerosis-associated myopathy","volume":"1108","author":"Ranque","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.autrev.2022.103261_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102431","article-title":"Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: a comparative study in 52 patients","volume":"19","author":"Chaigne","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2022.103261_bb0025","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2022.103261_bb0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/BOR.0000000000000336","article-title":"Myopathy in scleroderma and in other connective tissue diseases","volume":"28","author":"Paik","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2022.103261_bb0035","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1093\/rheumatology\/keab152","article-title":"The clinical phenotype of systemic sclerosis patients with anti-PM\/Scl antibodies: results from the EUSTAR cohort","volume":"60","author":"Lazzaroni","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2022.103261_bb0040","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.38428","article-title":"Clinical and serologic correlates of anti-PM\/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients","volume":"66","author":"D\u2019Aoust","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2022.103261_bb0045","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/diagnostics11061064","article-title":"Quantification of Antifibrillarin (anti-U3 RNP) antibodies: a new insight for patients with systemic sclerosis","volume":"11","author":"Benyamine","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.autrev.2022.103261_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/sji.12510","article-title":"The clinical relevance of Antifibrillarin (anti-U3-RNP) autoantibodies in systemic sclerosis","volume":"85","author":"Tall","year":"2017","journal-title":"Scand J Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2022.103261_bb0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/annrheumdis-2021-220004","article-title":"Anti-RuvBL1\/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern","volume":"81","author":"Vulsteke","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2022.103261_bb0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.22163","article-title":"Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement","volume":"66","author":"Kaji","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.autrev.2022.103261_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102851","article-title":"Histopathological features of systemic sclerosis-associated myopathy: a scoping review","volume":"20","author":"Lefebvre","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2022.103261_bb0070","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2008.095919","article-title":"A descriptive and prognostic study of systemic sclerosis-associated myopathies","volume":"68","author":"Ranque","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2022.103261_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/03009741003774626","article-title":"Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features","volume":"39","author":"Ranque","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2022.103261_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1759720X16671928","article-title":"Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation","volume":"9","author":"Corallo","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"10.1016\/j.autrev.2022.103261_bb0085","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-021-02305-3","article-title":"Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology","volume":"141","author":"Siegert","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.autrev.2022.103261_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12840","article-title":"Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis","volume":"48","author":"Ellezam","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.autrev.2022.103261_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13075-022-02768-z","article-title":"Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis","volume":"24","author":"Ross","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2022.103261_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000001039","article-title":"Myocarditis in scleroderma: an Underrecognized manifestation of the disease. JCR","volume":"26","author":"Theodorou","year":"2020","journal-title":"J Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2022.103261_bb0105","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/annrheumdis-2019-215145","article-title":"Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European scleroderma trials and research (EUSTAR) analysis","volume":"78","author":"Becker","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"33","key":"10.1016\/j.autrev.2022.103261_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021734","article-title":"Myopathy is a risk factor for poor prognosis of patients with systemic sclerosis: a retrospective cohort study","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.autrev.2022.103261_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009742.2013.868512","article-title":"Canadian scleroderma research group (CSRG). Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian scleroderma research group (CSRG) cohort","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2022.103261_bb0120","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/acr.23291","article-title":"Association of Fibrosing Myopathy in systemic sclerosis and higher mortality","volume":"69","author":"Paik","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2022.103261_bb0125","article-title":"Clinico-pathological phenotypes of systemic sclerosis associated myopathy: analysis of a multicenter large cohort","author":"Matas-Garc\u00eda","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2022.103261_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/03009742.2018.1477990","article-title":"Muscle endurance, strength, and active range of motion in patients with different subphenotypes in systemic sclerosis: a cross-sectional cohort study","volume":"48","author":"Pettersson","year":"2019","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2022.103261_bb0135","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/acr.22870","article-title":"Independent Association of Severity of muscle weakness with disability as measured by the health assessment questionnaire disability index in scleroderma","volume":"68","author":"Paik","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2022.103261_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nut.2018.03.046","article-title":"Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis","volume":"55\u201356","author":"Siegert","year":"2018","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.autrev.2022.103261_bb0145","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/annrheumdis-2012-202657","article-title":"Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study","volume":"72","author":"Elhai","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:25:54Z","timestamp":1761600354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1568997222002312"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103261","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis associated myopathy","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103261"}}